General and specific functions of exonic splicing silencers in splicing control.

Correct splice site recognition is critical in pre-mRNA splicing. We find that almost all of a diverse panel of exonic splicing silencer (ESS) elements alter splice site choice when placed between competing sites, consistently inhibiting use of intron-proximal 5' and 3' splice sites. Supporting a general role for ESSs in splice site definition, we found that ESSs are both abundant and highly conserved between alternative splice site pairs and that mutation of ESSs located between natural alternative splice site pairs consistently shifted splicing toward the intron-proximal site. Some exonic splicing enhancers (ESEs) promoted use of intron-proximal 5' splice sites, and tethering of hnRNP A1 and SF2/ASF proteins between competing splice sites mimicked the effects of ESS and ESE elements, respectively. Further, we observed that specific subsets of ESSs had distinct effects on a multifunctional intron retention reporter and that one of these subsets is likely preferred for regulation of endogenous intron retention events. Together, our findings provide a comprehensive picture of the functions of ESSs in the control of diverse types of splicing decisions.

[1]  R. Testi,et al.  Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. , 1996, Journal of immunology.

[2]  L. Gold,et al.  Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. , 1992, Journal of molecular biology.

[3]  P Scambler,et al.  Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. , 1998, Human molecular genetics.

[4]  C. Burd,et al.  RNA binding specificity of hnRNP A1: significance of hnRNP A1 high‐affinity binding sites in pre‐mRNA splicing. , 1994, The EMBO journal.

[5]  M. Olive,et al.  hnRNP A1 Recruited to an Exon In Vivo Can Function as an Exon Splicing Silencer , 1999, Molecular and Cellular Biology.

[6]  A. Krainer,et al.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. , 1994, Science.

[7]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[8]  Jean-François Fisette,et al.  Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA Splicing , 2006, PLoS biology.

[9]  Adrian R. Krainer,et al.  The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites , 1990, Cell.

[10]  L. Chasin,et al.  Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1. , 1999, Nucleic acids research.

[11]  K. Barringhaus,et al.  Intron Retention Generates a Novel Id3 Isoform That Inhibits Vascular Lesion Formation* , 2004, Journal of Biological Chemistry.

[12]  Adrian R. Krainer,et al.  Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2 , 1992, Cell.

[13]  J. Stévenin,et al.  Alternative Splicing of Intron 3 of the Serine/Arginine-rich Protein 9G8 Gene , 2001, The Journal of Biological Chemistry.

[14]  David Haussler,et al.  Transcriptome and Genome Conservation of Alternative Splicing Events in Humans and Mice , 2003, Pacific Symposium on Biocomputing.

[15]  A. Krainer,et al.  General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[17]  F. Clark,et al.  Understanding alternative splicing: towards a cellular code , 2005, Nature Reviews Molecular Cell Biology.

[18]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[19]  Gene W. Yeo,et al.  Variation in alternative splicing across human tissues , 2004, Genome Biology.

[20]  Dirk Holste,et al.  Single Nucleotide Polymorphism–Based Validation of Exonic Splicing Enhancers , 2004, PLoS biology.

[21]  Phillip A. Sharp,et al.  Regulation of CD44 Alternative Splicing by SRm160 and Its Potential Role in Tumor Cell Invasion , 2006, Molecular and Cellular Biology.

[22]  J. Manley,et al.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro , 1990, Cell.

[23]  M. Gabut,et al.  The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1α Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis , 2005, Molecular and Cellular Biology.

[24]  B. S. Baker,et al.  The control of alternative splicing at genes regulating sexual differentiation in D. melanogaster , 1988, Cell.

[25]  T. Maniatis,et al.  A systematic analysis of the factors that determine the strength of pre‐mRNA splicing enhancers , 1998, The EMBO journal.

[26]  R. Amann,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .

[27]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[28]  K. Lindblad-Toh,et al.  Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.

[29]  D. Baralle,et al.  Splicing in action: assessing disease causing sequence changes , 2005, Journal of Medical Genetics.

[30]  D. Helfman,et al.  Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. , 1999, Genes & development.

[31]  Gene W. Yeo,et al.  A Combinatorial Code for Splicing Silencing: UAGG and GGGG Motifs , 2005, PLoS biology.

[32]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.